OC-010 Final efficacy and safety in hcv genotype 1-infected patients receiving ombitasvir/paritaprevir/ritonavir and dasabuvir ± ribavirin: topaz-i results from the united kingdom and ireland

D Forton; A Ustianowski; R Aspinall; S Ryder; M Aldersley; D Mutimer; F Murray; PA McCormick; J Dillon; G Foster; K Agarwal; M Charafeddine; A Joy; L Liu; R-M Stanica; T Pilot-Matias; M O’Meara; C Pollard; DE Cohen; S Norris

doi:10.1136/gutjnl-2017-314472.10

Article info

Liver Section Free Papers

OC-010 Final efficacy and safety in hcv genotype 1-infected patients receiving ombitasvir/paritaprevir/ritonavir and dasabuvir ± ribavirin: topaz-i results from the united kingdom and ireland

Authors

D Forton 1St. George’s Hospital, London PubMed articles Google scholar articles
A Ustianowski 2Infectious Diseases and Tropical Medicines Unit, North Manchester General Hospital, Manchester PubMed articles Google scholar articles
R Aspinall 3D8 Research Clinic, Queen Alexandra Hospital, Portsmouth PubMed articles Google scholar articles
S Ryder 4Nottingham Digestive Diseases Centre, University Hospital Queen’s Medical Centre, Nottingham PubMed articles Google scholar articles
M Aldersley 5St. James University Hospital, Leeds PubMed articles Google scholar articles
D Mutimer 6Queen Elizabeth Hospital, University Hospitals Birmingham NHS, Birmingham, UK PubMed articles Google scholar articles
F Murray 7Hepatology, Beaumont Hospital PubMed articles Google scholar articles
PA McCormick 8Liver Unit, St. Vincent’s University Hospital, Dublin, Ireland PubMed articles Google scholar articles
J Dillon 9Ninewells Hospital, Dundee PubMed articles Google scholar articles
G Foster 10Royal London Hospital, London PubMed articles Google scholar articles
K Agarwal 11North Manchester General Hospital, Manchester, UK PubMed articles Google scholar articles
M Charafeddine 12AbbVie Inc PubMed articles Google scholar articles
A Joy 13AbbVie, North Chicago, IL PubMed articles Google scholar articles
L Liu 13AbbVie, North Chicago, IL PubMed articles Google scholar articles
R-M Stanica 14AbbVie, North Cicago, IL, USA PubMed articles Google scholar articles
T Pilot-Matias 13AbbVie, North Chicago, IL PubMed articles Google scholar articles
M O’Meara 13AbbVie, North Chicago, IL PubMed articles Google scholar articles
C Pollard 13AbbVie, North Chicago, IL PubMed articles Google scholar articles
DE Cohen 13AbbVie, North Chicago, IL PubMed articles Google scholar articles
S Norris 15St James Hospital, Dublin, Ireland PubMed articles Google scholar articles

Citation

Forton D, Ustianowski A, Aspinall R, et al

OC-010 Final efficacy and safety in hcv genotype 1-infected patients receiving ombitasvir/paritaprevir/ritonavir and dasabuvir ± ribavirin: topaz-i results from the united kingdom and ireland

Gut 2017;66:A5-A6.

Publication history

First published June 17, 2017.

Online issue publication

March 01, 2018

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Main menu

Authors

Citation

Publication history

Request permissions

Copyright information

Log in using your username and password

Main menu

Log in using your username and password

You are here

Authors

Citation

Publication history

Request permissions

Copyright information

Read the full text or download the PDF:

Log in using your username and password